Adult height in children with idiopathic short stature treated with growth hormone

Idiopathic short stature (ISS) includes a heterogeneous group of patients with common characteristics to those of familial short stature and constitutional delay. Some authors state that these children can often respond to GM treatment, thus increasing their adult height. The aims of this study were to determine the effect of GE I treatment (0.5-0.7 IU/kg/week) and the influence of some initial variables on adult height in patients with ISS. It was a nonrandomized, observational study of 30 boys with ISS and a historical control group of 42 patients. The patients were followed until achieving their adult height, The mean height gain of the treated group attributable to GH was 4.5 cm, A stepwise regression model considering predicted adult height and target height as independent variables and final height as dependent variable gave an R(2)coefficient of 0,38. We conclude that GH significantly increases final height in boys with ISS.